| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4000 | 2014 |
| A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ... New England Journal of Medicine 362 (5), 387-401, 2010 | 3299 | 2010 |
| Natalizumab plus interferon beta-1a for relapsing multiple sclerosis RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... New England Journal of Medicine 354 (9), 911-923, 2006 | 1727 | 2006 |
| Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification K Hua, J Zhang, S Wakana, H Jiang, X Li, DS Reich, PA Calabresi, ... Neuroimage 39 (1), 336-347, 2008 | 1591 | 2008 |
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ... Annals of neurology 66 (4), 460-471, 2009 | 1086 | 2009 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 1021 | 2019 |
| Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ... The Lancet 378 (9805), 1779-1787, 2011 | 957 | 2011 |
| Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial PA Calabresi, EW Radue, D Goodin, D Jeffery, KW Rammohan, AT Reder, ... The Lancet Neurology 13 (6), 545-556, 2014 | 942 | 2014 |
| Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis JB Fisher, DA Jacobs, CE Markowitz, SL Galetta, NJ Volpe, ... Ophthalmology 113 (2), 324-332, 2006 | 881 | 2006 |
| Saccade preparation inhibits reorienting to recently attended locations. RD Rafal, PA Calabresi, CW Brennan, TK Sciolto Journal of Experimental Psychology: Human perception and performance 15 (4), 673, 1989 | 725 | 1989 |
| Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis A Petzold, JF de Boer, S Schippling, P Vermersch, R Kardon, A Green, ... The Lancet Neurology 9 (9), 921-932, 2010 | 722 | 2010 |
| Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, ... Proceedings of the National Academy of Sciences 103 (46), 17414-17419, 2006 | 619 | 2006 |
| Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ... Annals of neurology 67 (4), 452-461, 2010 | 616 | 2010 |
| Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008 | 612 | 2008 |
| Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled … L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ... Nature medicine 6 (10), 1176-1182, 2000 | 610 | 2000 |
| Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity MD Kornberg, P Bhargava, PM Kim, V Putluri, AM Snowman, N Putluri, ... Science 360 (6387), 449-453, 2018 | 593 | 2018 |
| Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA SS Soldan, R Berti, N Salem, P Secchiero, L Flamand, PA Calabresi, ... Nature medicine 3 (12), 1394-1397, 1997 | 587 | 1997 |
| The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS H Wulff, PA Calabresi, R Allie, S Yun, M Pennington, C Beeton, ... The Journal of clinical investigation 111 (11), 1703-1713, 2003 | 557 | 2003 |
| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 544 | 2017 |
| Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis E Gordon-Lipkin, B Chodkowski, DS Reich, SA Smith, M Pulicken, ... Neurology 69 (16), 1603-1609, 2007 | 515 | 2007 |
Shiv SaidhaJohns HopkinsVerified email at jhmi.edu